Abstract
Objective
To identify correlates of quality of life (QoL) measured with the Quality of Life Scale (QOLS) in participants of a multidisciplinary day hospital treatment program for fibromyalgia (FM).
Methods
In this cross-sectional, observational study, “real world” data from 480 FM patients including socio-demographics, pain variables and questionnaires such as the SF-36, Beck Depression Inventory (BDI), Multiphasic Pain Inventory (MPI), SCL-90-R and others were categorized according to the components (body structure and function, activities and participation, personal factors, environmental factors) of the International Classification of Functioning (ICF). For every ICF component, a linear regression analysis with QOLS as the dependent variable was computed. A final comprehensive model was calculated on the basis of the results of the five independent analyses.
Results
The following variables could be identified as main correlates for QoL in FM, explaining 56% of the variance of the QOLS (subscale/questionnaire and standardized beta in parenthesis): depression (− 0.22), pain-related interference with everyday life (− 0.19), general activity (0.13), general health perception (0.11), punishing response from others (− 0.11), work status (− 0.10), vitality (− 0.11) and cognitive difficulties (− 0.12). Pain intensity or frequency was not an independent correlate.
Conclusions
More than 50% of QoL variance could be explained by distinct self-reported variables with neither pain intensity nor pain frequency playing a major role. Therefore, FM treatment should not primarily concentrate on pain but should address multiple factors within multidisciplinary therapy.
Similar content being viewed by others
References
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P et al (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia Report of the Multicenter Criteria Committee. Arthritis Rheum 33(2):160–172
Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L, Martin SA (2008) Patient perspectives on the impact of fibromyalgia. Patient Educ Couns 73(1):114–120. https://doi.org/10.1016/j.pec.2008.06.005
Henriksson C, Gundmark I, Bengtsson A, Ek AC (1992) Living with fibromyalgia consequences for everyday life. Clin J Pain 8(2):138–144
Lempp HK, Hatch SL, Carville SF, Choy EH (2009) Patients' experiences of living with and receiving treatment for fibromyalgia syndrome: a qualitative study. BMC Musculoskelet Disord 10:124. https://doi.org/10.1186/1471-2474-10-124
Hoffman DL, Dukes EM (2008) The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract 62(1):115–126. https://doi.org/10.1111/j.1742-1241.2007.01638.x
Burckhardt CS, Clark SR, Bennett RM (1993) Fibromyalgia and quality of life: a comparative analysis. J Rheumatol 20(3):475–479
Offenbacher M, Sauer S, Kohls N, Waltz M, Schoeps P (2012) Quality of life in patients with fibromyalgia: validation and psychometric properties of the German Quality of Life Scale (QOLS-G). Rheumatol Int 32(10):3243–3252. https://doi.org/10.1007/s00296-011-2184-4
Hawley DJ, Wolfe F (1991) Pain, disability, and pain/disability relationships in seven rheumatic disorders: a study of 1,522 patients. J Rheumatol 18(10):1552–1557
Bucourt E, Martaille V, Goupille P, Joncker-Vannier I, Huttenberger B, Reveillere C, Mulleman D, Courtois AR (2019) A comparative study of fibromyalgia, rheumatoid arthritis, Spondyloarthritis, and Sjogren’s Syndrome; impact of the disease on quality of life, psychological adjustment, and use of coping strategies. Pain Med. https://doi.org/10.1093/pm/pnz255
Karimi M, Brazier J (2016) Health, health-related quality of life, and quality of life: what is the difference? Pharmacoeconomics 34(7):645–649. https://doi.org/10.1007/s40273-016-0389-9
Ferrans CE, Zerwic JJ, Wilbur JE, Larson JL (2005) Conceptual model of health-related quality of life. J Nurs Scholarsh 37(4):336–342
Mason VL, Skevington SM, Osborn M (2004) Development of a pain and discomfort module for use with the WHOQOL-100. Qual Life Res 13(6):1139–1152
Cummins RA (2005) Moving from the quality of life concept to a theory. J Intellect Disabil Res 49(Pt 10):699–706. https://doi.org/10.1111/j.1365-2788.2005.00738.x
Ferrans CE (1990) Quality of life: conceptual issues. Semin Oncol Nurs 6(4):248–254
Ferrans CE (1996) Development of a conceptual model of quality of life. Sch Inq Nurs Pract 10(3):293–304
Jones KD, Burckhardt CS, Deodhar AA, Perrin NA, Hanson GC, Bennett RM (2008) A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgia. Arthritis Rheum 58(2):612–622. https://doi.org/10.1002/art.23203
Baranowsky J, Klose P, Musial F, Hauser W, Dobos G, Langhorst J (2009) Qualitative systemic review of randomized controlled trials on complementary and alternative medicine treatments in fibromyalgia. Rheumatol Int 30(1):23. https://doi.org/10.1007/s00296-009-1120-3
Thorpe J, Shum B, Moore RA, Wiffen PJ, Gilron I (2018) Combination pharmacotherapy for the treatment of fibromyalgia in adults. Cochrane Database Syst Rev 2:010585. https://doi.org/10.1002/14651858.CD010585.pub2
Langhorst J, Klose P, Dobos GJ, Bernardy K, Hauser W (2013) Efficacy and safety of meditative movement therapies in fibromyalgia syndrome: a systematic review and meta-analysis of randomized controlled trials. Rheumatol Int 33(1):193–207. https://doi.org/10.1007/s00296-012-2360-1
Schiltenwolf M, Eidmann U, Kollner V, Kuhn T, Offenbacher M, Petzke F, Sarholz M, Weigl M, Wolf B, Hauser W (2017) Multimodal therapy of fibromyalgia syndrome: updated guidelines 2017 and overview of systematic review articles. Schmerz 31(3):285–288. https://doi.org/10.1007/s00482-017-0205-2
Kramer SDL, Kohls N, Offenbaecher M, Winkelmann A (2020) The importance of daily activity for reducing fibromyalgia symptoms: a retrospective, “real world” data comparison of two multimodal treatment programs. Arch Rheumatol 2:9–45
Lautenschlager J, Seglias J, Bruckle W, Muller W (1991) Comparisons of spontaneous pain and tenderness in patients with primary fibromyalgia. Clin Rheumatol 10(2):168–173
Offenbaecher M, Waltz M, Schoeps P (2000) Validation of a German version of the fibromyalgia impact questionnaire (FIQ-G). J Rheumatol 27(8):1984–1988
Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483
Bullinger M (1995) German translation and psychometric testing of the SF-36 health survey: preliminary results from the IQOLA Project. Internat Q Life Asses Soc Sci Med 41(10):1359–1366. https://doi.org/10.1016/0277-9536(95)00115-n
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571. https://doi.org/10.1001/archpsyc.1961.01710120031004
Hautzinger M (1991) The beck depression inventory in clinical practice. Nervenarzt 62(11):689–696
Derogatis LR, Lipman RS, Covi L (1973) SCL-90: an outpatient psychiatric rating scale–preliminary report. Psychopharmacol Bull 9(1):13–28
Franke GH (1995) Die Symptom-Checkliste von Derogatis (Deutsche Version). Göttingen (Germany), Beltz Test
Rosenstiel AK, Keefe FJ (1983) The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment. Pain 17(1):33–44. https://doi.org/10.1016/0304-3959(83)90125-2
Hassett AL, Cone JD, Patella SJ, Sigal LH (2000) The role of catastrophizing in the pain and depression of women with fibromyalgia syndrome. Arthritis Rheum 43(11):2493–2500
Flor H, Rudy TE, Birbaumer N, Streit B, Schugens MM (1990) The applicability of the West Haven-Yale multidimensional pain inventory in German-speaking countries Data on the reliability and validity of the MPI-D. Schmerz 4(2):82–87
WHO (2001) International classification of functioning, disability and health: ICF. World Health Organization, Geneva
Bickenbach JE, Chatterji S, Badley EM, Ustun TB (1999) Models of disablement, universalism and the international classification of impairments, disabilities and handicaps. Soc Sci Med 48(9):1173–1187
Ewert T, Allen DD, Wilson M, Ustun B, Stucki G (2010) Validation of the international classification of functioning disability and health framework using multidimensional item response modeling. Disabil Rehabil 32(17):1397–1405. https://doi.org/10.3109/09638281003611037
Cieza A, Geyh S, Chatterji S, Kostanjsek N, Ustun B, Stucki G (2005) ICF linking rules: an update based on lessons learned. J Rehabil Med 37(4):212–218. https://doi.org/10.1080/16501970510040263
Neumann L, Berzak A, Buskila D (2000) Measuring health status in Israeli patients with fibromyalgia syndrome and widespread pain and healthy individuals: utility of the short form 36-item health survey (SF-36). Semin Arthritis Rheum 29(6):400–408
Silverman S, Sadosky A, Evans C, Yeh Y, Alvir JM, Zlateva G (2010) Toward characterization and definition of fibromyalgia severity. BMC Musculoskelet Disord 11:66. https://doi.org/10.1186/1471-2474-11-66
Humphrey L, Arbuckle R, Mease P, Williams DA, Samsoe BD, Gilbert C (2010) Fatigue in fibromyalgia: a conceptual model informed by patient interviews. BMC Musculoskelet Disord 11:216. https://doi.org/10.1186/1471-2474-11-216
Verbunt JA, Pernot DH, Smeets RJ (2008) Disability and quality of life in patients with fibromyalgia. Health Qual Life Outcomes 6:8. https://doi.org/10.1186/1477-7525-6-8
Lame IE, Peters ML, Vlaeyen JW, Kleef M, Patijn J (2005) Quality of life in chronic pain is more associated with beliefs about pain, than with pain intensity. Eur J Pain 9(1):15–24. https://doi.org/10.1016/j.ejpain.2004.02.006
Bernard AL, Prince A, Edsall P (2000) Quality of life issues for fibromyalgia patients. Arthritis Care Res 13(1):42–50
Bossema ER, Kool MB, Cornet D, Vermaas P, de Jong M, van Middendorp H, Geenen R (2012) Characteristics of suitable work from the perspective of patients with fibromyalgia. Rheumatology (Oxford) 51(2):311–318. https://doi.org/10.1093/rheumatology/ker312
Uguz F, Cicek E, Salli A, Karahan AY, Albayrak I, Kaya N, Ugurlu H (2010) Axis I and Axis II psychiatric disorders in patients with fibromyalgia. Gen Hosp Psychiatry 32(1):105–107. https://doi.org/10.1016/j.genhosppsych.2009.07.002
Bradley LA (2009) Pathophysiology of fibromyalgia. Am J Med 122(12 Suppl):S22–30. https://doi.org/10.1016/j.amjmed.2009.09.008
Bair MJ, Wu J, Damush TM, Sutherland JM, Kroenke K (2008) Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med 70(8):890–897. https://doi.org/10.1097/PSY.0b013e318185c510
Galvez-Sanchez CM, Montoro CI, Duschek S, Reyes Del Paso GA (2020) Depression and trait-anxiety mediate the influence of clinical pain on health-related quality of life in fibromyalgia. J Affect Disord 265:486–495. https://doi.org/10.1016/j.jad.2020.01.129
Okifuji A, Turk DC, Sherman JJ (2000) Evaluation of the relationship between depression and fibromyalgia syndrome: why aren’t all patients depressed? J Rheumatol 27(1):212–219
Park DC, Glass JM, Minear M, Crofford LJ (2001) Cognitive function in fibromyalgia patients. Arthritis Rheum 44(9):2125–2133
Suhr JA (2003) Neuropsychological impairment in fibromyalgia: relation to depression, fatigue, and pain. J Psychosom Res 55(4):321–329
Penninx BW, Guralnik JM, Bandeen-Roche K, Kasper JD, Simonsick EM, Ferrucci L, Fried LP (2000) The protective effect of emotional vitality on adverse health outcomes in disabled older women. J Am Geriatr Soc 48(11):1359–1366
Schaefer C, Chandran A, Hufstader M, Baik R, McNett M, Goldenberg D, Gerwin R, Zlateva G (2011) The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States. Health Qual Life Outcomes 9:71. https://doi.org/10.1186/1477-7525-9-71
Da Costa D, Dobkin PL, Fitzcharles MA, Fortin PR, Beaulieu A, Zummer M, Senecal JL, Goulet JR, Rich E, Choquette D, Clarke AE (2000) Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus. J Rheumatol 27(2):365–372
Soderberg S, Lundman B (2001) Transitions experienced by women with fibromyalgia. Health Care Women Int 22(7):617–631. https://doi.org/10.1080/07399330127169
Phillips LJ, Stuifbergen AK (2010) The relevance of depressive symptoms and social support to disability in women with multiple sclerosis or fibromyalgia. Int J Rehabil Res 33(2):142–150. https://doi.org/10.1097/MRR.0b013e3283310cce
Calandre EP, Garcia-Carrillo J, Garcia-Leiva JM, Rico-Villademoros F, Molina-Barea R, Rodriguez-Lopez CM (2011) Subgrouping patients with fibromyalgia according to the results of the Fibromyalgia impact questionnaire: a replication study. Rheumatol Int 31(12):1555–1559. https://doi.org/10.1007/s00296-010-1521-3
Kurtze N, Gundersen KT, Svebak S (1999) Quality of life, functional disability and lifestyle among subgroups of fibromyalgia patients: the significance of anxiety and depression. Br J Med Psychol 72(Pt 4):471–484
Liedberg GM, Henriksson CM (2002) Factors of importance for work disability in women with fibromyalgia: an interview study. Arthritis Rheum 47(3):266–274. https://doi.org/10.1002/art.10454
Preece JC, Sandberg JG (2005) Family resilience and teh management of fibromyalgia: implications for family therapists. Contemorary Family Therapy 27:559–576
Steptoe A, Marmot M (2003) Burden of psychosocial adversity and vulnerability in middle age: associations with biobehavioral risk factors and quality of life. Psychosom Med 65(6):1029–1037
Lopez-Martinez AE, Esteve-Zarazaga R, Ramirez-Maestre C (2008) Perceived social support and coping responses are independent variables explaining pain adjustment among chronic pain patients. J Pain 9(4):373–379. https://doi.org/10.1016/j.jpain.2007.12.002
McCracken LM, Vowles KE, Eccleston C (2004) Acceptance of chronic pain: component analysis and a revised assessment method. Pain 107(1–2):159–166
Van Wilgen CP, Kaptein AA, Brink MS (2010) Illness perceptions and mood states are associated with injury-related outcomes in athletes. Disabil Rehabil 32(19):1576–1585. https://doi.org/10.3109/09638281003596857
Kaptein AA, Klok T, Moss-Morris R, Brand PL (2010) Illness perceptions: impact on self-management and control in asthma. Curr Opin Allergy Clin Immunol 10(3):194–199. https://doi.org/10.1097/ACI.0b013e32833950c1
Hayes SM, Myhal GC, Thornton JF, Camerlain M, Jamison C, Cytryn KN, Murray S (2010) Fibromyalgia and the therapeutic relationship: where uncertainty meets attitude. Pain Res Management J Canadian Pain Society J Soc Can Trait Douleur 15(6):385–391
Perrot S, Choy E, Petersel D, Ginovker A, Kramer E (2012) Survey of physician experiences and perceptions about the diagnosis and treatment of fibromyalgia. BMC Health Services Res 12:356. https://doi.org/10.1186/1472-6963-12-356
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
All individuals participating at the multidisciplinary treatment program gave their written informed consent for analyzing their data.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Offenbaecher, M., Kohls, N., Ewert, T. et al. Pain is not the major determinant of quality of life in fibromyalgia: results from a retrospective “real world” data analysis of fibromyalgia patients. Rheumatol Int 41, 1995–2006 (2021). https://doi.org/10.1007/s00296-020-04702-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-020-04702-5